查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1971525

外科/锐器清创市场 - 全球产业规模、份额、趋势、机会、预测、区域及竞争格局（2021-2031）

Surgical/Sharp Debridement Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球外科/锐器清创市场预计将从 2025 年的 2.3444 亿美元成长到 2031 年的 3.1941 亿美元，复合年增长率为 5.29%。

此手术包括使用无菌器械（例如剪刀和手术刀）切除坏死和感染组织，从而促进健康组织的再生。推动此成长要素包括慢性疾病（尤其是糖尿病足溃疡）发生率的上升，以及全球人口老化导致复杂伤口增加。根据国际糖尿病联盟2024年的数据，全球约有5.89亿成年人患有糖尿病，这一数字凸显了有效溃疡管理的日益增长的需求。此外，术后环境中严格的感染控制也是此手术持续发展的重要原因。

市场概览
预测期 2027-2031
市场规模：2025年 2.3444亿美元
市场规模：2031年 3.1941亿美元
复合年增长率：2026-2031年 5.29%
成长最快的细分市场
最大的市场 北美洲

另一方面，阻碍市场发展的主要障碍是全球范围内掌握这项侵入性技术的医疗专业人员短缺。锐器清创术需要极高的精准度以避免损伤健康组织，而合格专业人员的匮乏限制了患者获得这些必要治疗的机会。这种临床专业知识的缺乏常常迫使医疗机构采用速度较慢、效率较低的保守治疗策略，限制了市场渗透率的提升。

市场驱动因素

全球肥胖及其相关代谢疾病的日益流行，是外科清创领域发展的重要驱动力。高体重指数（BMI）族群常伴随静脉功能不全和循环障碍，导致复杂的溃疡，需要精准切除坏死组织以促进癒合。世界卫生组织（WHO）在2024年3月「世界肥胖日」发布的新闻稿中指出，全球超过10亿人患有肥胖症，这群人极易发生与皮肤健康相关的併发症。如此庞大的患者群体需要定期进行彻底清创，以控制微生物附着量（微生物负荷）并预防全身性行为感染，从而确保了对熟练的清创医师和无菌清创器械的稳定临床需求。

同时，对先进创伤护理管理的需求日益增长，使得清创术的使用显着增加，并成为后续治疗的先决条件。细胞疗法和负压伤口治疗等先进疗法依赖于清除坏死组织的清洁伤口床，而清创术正是实现这一通讯协定的有效途径。例如，史密斯医疗（Smith & Nephew）在其2024年2月发布的2023财年年度报告中指出，其先进伤口管理部门创造了16亿美元的收入，这充分说明了这些综合护理方案的规模。此外，根据Healogics公司2024年的数据，美国约有670万人患有难以癒合的慢性伤口，凸显了需要积极进行维护性清创以降低发病率的病例的紧迫性。

市场挑战

熟练医护人员的短缺是外科/锐器清创领域发展的主要障碍。与自动化治疗方案不同，锐器清创术是一项劳动密集且侵入性强的手术，需要精湛的技巧和良好的临床判断才能安全地清除坏死组织。此手术的成功完全取决于能否获得专业的创伤护理护理师和认证外科医生。因此，这些合格专业人员的短缺造成了诊所和医院的营运瓶颈，从物理上限制了可进行的手术数量，并直接阻碍了潜在的产生收入。

近期统计数据显示，专科医师的供应缺口日益扩大，进一步印证了这个短缺问题。美国医学院协会（AAMC）预测，到2036年，医疗产业将面临1万至1.99万名外科医师的缺口。专科医师的短缺迫使医疗机构以自体溶解和酵素疗法等保守疗法取代锐性清创术。虽然这些疗法减轻了医护人员的负担，但也导致手术频率和患者周转率下降，最终阻碍了市场的整体经济成长。

市场趋势

人工智慧驱动的伤口评估和记录系统的引入正在改变市场格局，它能够自动测量坏死组织，并规范锐性清创术的临床证据。人工智慧演算法使临床医生只需拍摄伤口影像即可自动计算组织成分和表面积，从而实现精确的时间序列监测，同时最大限度地减少手动测量的主观性。这种数位化检验在基于价值的医疗体系下对于报销至关重要，它为侵入性清除坏死组织的必要性提供了无可辩驳的证据。 Swift Medical 于 2024 年 1 月发布的新闻稿证实了这一趋势，该新闻稿宣布了新一轮资金筹措，并指出其人工智慧增强平台已被北美 4000 多家医疗机构使用，这表明数位化工具正在迅速渗透到临床工作流程中。

此外，即时生物膜引导萤光成像技术的引入，标誌着清创过程中从依赖临床症状转向客观细菌可视化的重大转变。此技术能够即时显示生物膜细菌，引导临床医师操作器械，确保彻底清除肉眼难以察觉的定植组织。这种精准性显着提高了伤口床准备的有效性，并比经常漏诊皮下感染的标准护理方法更有效地降低微生物附着量。在2024年10月发布的新闻稿《MolecuLight萤光成像：床边生物膜检测的变革者》中，对比研究表明，萤光成像在生物膜检测方面具有高达84%的灵敏度，显着优于传统的视觉评估方法。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球外科/锐器清创市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美外科/锐器清创市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲外科/锐器清创市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区外科/锐器清创市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲外科/锐器清创市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲外科/锐器清创市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球外科/锐器清创市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Smith & Nephew plc
  • Medtronic plc
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Integra LifeSciences Corporation
  • CONMED Corporation
  • Coloplast A/S
  • Johnson & Johnson
  • 3M Company
  • DeRoyal Industries, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27192

The Global Surgical or Sharp Debridement Market is projected to expand from USD 234.44 Million in 2025 to USD 319.41 Million by 2031, reflecting a compound annual growth rate (CAGR) of 5.29%. This procedure entails the use of sterile instruments, such as scissors or scalpels, to excise necrotic or infected tissue and stimulate the regeneration of healthy tissue. A primary growth driver is the rising incidence of chronic ailments, specifically diabetic foot ulcers, alongside an aging global demographic prone to complex wounds. Data from the International Diabetes Federation in 2024 indicates that roughly 589 million adults globally were living with diabetes, a statistic that underscores the escalating need for effective ulcer management. Furthermore, the essential need for rigorous infection control in post-surgical settings provides foundational support for the continued demand for these interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 234.44 Million
Market Size 2031USD 319.41 Million
CAGR 2026-20315.29%
Fastest Growing Segment
Largest MarketNorth America

Conversely, a major obstacle hindering market progression is the worldwide scarcity of healthcare professionals proficient in this invasive technique. Sharp debridement demands distinct precision to prevent harm to viable tissue, and the lack of certified specialists restricts patient access to these necessary treatments. This deficiency in clinical expertise frequently compels healthcare providers to utilize slower, less efficient conservative management tactics, which ultimately limits broader market penetration.

Market Driver

The escalating global prevalence of obesity and associated metabolic disorders acts as a significant propellant for the surgical debridement sector. Individuals with high body mass indices frequently experience venous insufficiency and compromised circulation, resulting in complex ulcers that demand the precise excision of devitalized tissue to trigger healing processes. As per the 'World Obesity Day 2024' news release by the World Health Organization in March 2024, over 1 billion individuals globally were living with obesity, creating a demographic highly susceptible to skin integrity complications. This substantial patient population requires regular sharp debridement to control bioburden and avert systemic infections, thereby ensuring a steady clinical demand for skilled practitioners and sterile debridement tools.

Concurrently, the rising request for advanced wound care management significantly boosts the utilization of sharp debridement as an essential prerequisite for follow-up therapies. Advanced treatments, such as cellular-based products or negative pressure wound therapy, depend on a clean wound bed devoid of necrosis, a condition effectively achieved through sharp debridement. Highlighting the scale of these integrated care protocols, Smith+Nephew reported in February 2024 within their 'Annual Report 2023' that their Advanced Wound Management division secured $1.6 billion in revenue. Moreover, data from Healogics in 2024 indicated that approximately 6.7 million individuals in the United States were affected by non-healing chronic wounds, emphasizing the urgent volume of cases necessitating aggressive maintenance debridement to lower morbidity rates.

Market Challenge

The lack of proficient healthcare professionals poses a formidable hurdle to the growth of the surgical or sharp debridement sector. Unlike automated therapeutic options, sharp debridement is a labor-intensive, invasive process requiring exceptional manual dexterity and sound clinical judgment to safely remove necrotic tissue. The success of the procedure relies entirely on the accessibility of specialized wound care nurses and board-certified surgeons. As a result, the shortage of these qualified experts generates operational bottlenecks within clinics and hospitals, physically restricting the volume of performable procedures and directly limiting potential revenue generation.

Recent statistics regarding the widening gap in specialist availability further corroborate this workforce limitation. According to the Association of American Medical Colleges in 2024, the healthcare industry is expected to encounter a surgeon shortfall ranging from 10,000 to 19,900 by 2036. This scarcity of available specialists obliges healthcare providers to replace sharp debridement with conservative alternatives, such as autolytic or enzymatic methods. Although these substitutes place fewer demands on staff, they lead to reduced procedure frequency and slower patient turnover, thereby impeding the overall financial expansion of the market.

Market Trends

The adoption of AI-Driven Wound Assessment and Documentation is transforming the market by automating the measurement of necrotic tissue, thereby standardizing the clinical rationale for sharp debridement. Artificial intelligence algorithms now enable clinicians to capture wound imagery that automatically computes tissue composition and surface area, minimizing the subjectivity inherent in manual measurements while ensuring precise longitudinal monitoring. This digital verification is becoming essential for reimbursement within value-based care frameworks, offering irrefutable proof of the need for the invasive removal of devitalized tissue. As evidence of this trend, Swift Medical's 'Swift Medical Announces New Financing Round' press release in January 2024 noted that their AI-enhanced platform is now utilized by over 4,000 healthcare facilities in North America, signaling the rapid assimilation of digital tools into clinical workflows.

Additionally, the incorporation of Fluorescence Imaging for Real-Time Biofilm Guidance marks a pivotal transition from reliance on clinical symptoms to the use of objective bacterial visualization during debridement. This technology highlights biofilm bacteria in real-time, directing the clinician's instruments to guarantee the thorough removal of colonized tissue that might otherwise escape detection by the naked eye. Such precision vastly enhances the effectiveness of wound bed preparation, reducing bioburden more proficiently than standard care methods which frequently fail to identify sub-surface infections. In an October 2024 news release titled 'MolecuLight's Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection,' a comparative study demonstrated that fluorescence imaging provided a superior sensitivity rate of 84% for biofilm detection, substantially exceeding the limits of traditional visual assessment.

Key Market Players

  • Smith & Nephew plc
  • Medtronic plc
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Integra LifeSciences Corporation
  • CONMED Corporation
  • Coloplast A/S
  • Johnson & Johnson
  • 3M Company
  • DeRoyal Industries, Inc.

Report Scope

In this report, the Global Surgical or Sharp Debridement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Surgical or Sharp Debridement Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Surgical or Sharp Debridement Market.

Available Customizations:

Global Surgical or Sharp Debridement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Surgical or Sharp Debridement Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Region
    • 5.2.2. By Company (2025)
  • 5.3. Market Map

6. North America Surgical or Sharp Debridement Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Surgical or Sharp Debridement Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
    • 6.3.2. Canada Surgical or Sharp Debridement Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
    • 6.3.3. Mexico Surgical or Sharp Debridement Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast

7. Europe Surgical or Sharp Debridement Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Surgical or Sharp Debridement Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
    • 7.3.2. France Surgical or Sharp Debridement Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
    • 7.3.3. United Kingdom Surgical or Sharp Debridement Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
    • 7.3.4. Italy Surgical or Sharp Debridement Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
    • 7.3.5. Spain Surgical or Sharp Debridement Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast

8. Asia Pacific Surgical or Sharp Debridement Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Surgical or Sharp Debridement Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
    • 8.3.2. India Surgical or Sharp Debridement Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
    • 8.3.3. Japan Surgical or Sharp Debridement Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
    • 8.3.4. South Korea Surgical or Sharp Debridement Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
    • 8.3.5. Australia Surgical or Sharp Debridement Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast

9. Middle East & Africa Surgical or Sharp Debridement Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Surgical or Sharp Debridement Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
    • 9.3.2. UAE Surgical or Sharp Debridement Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
    • 9.3.3. South Africa Surgical or Sharp Debridement Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast

10. South America Surgical or Sharp Debridement Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Surgical or Sharp Debridement Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
    • 10.3.2. Colombia Surgical or Sharp Debridement Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
    • 10.3.3. Argentina Surgical or Sharp Debridement Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Surgical or Sharp Debridement Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Smith & Nephew plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Medtronic plc
  • 15.3. B. Braun Melsungen AG
  • 15.4. Stryker Corporation
  • 15.5. Integra LifeSciences Corporation
  • 15.6. CONMED Corporation
  • 15.7. Coloplast A/S
  • 15.8. Johnson & Johnson
  • 15.9. 3M Company
  • 15.10. DeRoyal Industries, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer